SiR.-In 1977, a project of the programme on clinical oncology of the UICC published a system of guide-lines recommended for use in clinical trials designed to assess the objective response of locally advanced or metastatic mammary cancer to treatment (Hayward et al., 1977 (ii) Partial response. 50% or more decrease in measurable lesions, and unequivocal improvement in evaluable but non-measurable lesions, with no new lesions developing; determined by 2 observations not less than 4 weeks apart.
No change and progressive disease.-These categories remain as defined previously.
Duration of response
It is recommended that: (1) The period of overall response be from the date of start of treatment to the date of first observation of progressive disease.
(2) The period of complete response be from the date complete response was first recorded to the date of first observation of progressive disease.
(3) In those patients who just achieve a partial response, only the period of overall response should be recorded. Thus, in patients achieving a complete objective remission the duration of this complete response should be distinguished from the longer overall, response recorded in these cases.
